Molina Healthcare (MHG) AI Stock Analysis

8 Followers

Molina Healthcare

(XETRA:MHG)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Improving Medicaid Rate EnvironmentImproving Medicaid rate adequacy could stabilize the company’s largest business after several years of medical cost trend exceeding rates. If reimbursement continues to cover underlying cost growth, Medicaid margins may recover, supporting more durable earnings and cash generation.

Negative Factors

Profitability CompressionThe move from healthy prior-year margins to a small TTM net loss shows reduced earnings resilience. Lower profitability limits internal reinvestment capacity and leaves results more sensitive to medical utilization, reimbursement timing, and execution across the company’s government contracts.

Molina Healthcare (MHG) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 10.95B
Dividend Yield: ―
Average Volume (3M): 74
Price to Earnings (P/E): -343.6
Beta (1Y): -0.11
Revenue Growth: -5.83%
EPS Growth: -105.41%
Country: Germany
Employees: 19,000
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Healthcare Plans

Molina Healthcare Business Overview & Revenue Model

Company Description

Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare program...

Molina Healthcare Earnings Call Summary

Earnings Call Date:Oct 21, 2026(Q3-2026)|% Change Since:-2.63%|Next Earnings Date:Feb 10, 2027

Earnings Call SentimentPositive

The call was broadly optimistic. Third-quarter results were in line with expectations, 2026 guidance was reaffirmed, the balance sheet remained strong, and management highlighted improving Medicaid rate conditions, strong duals performance, the successful Florida CMS implementation, and preliminary 2027 earnings building blocks above $9.50 per share. The main challenges were elevated medical cost trend, membership declines, current-year MAPD and Marketplace losses, the initial Florida CMS loss, and delays to the Georgia and Texas contracts. Overall, the number and significance of the positive developments outweighed the stated challenges.

Positive Updates

Third-Quarter Results Met Expectations

Molina reported approximately $10.5 billion of premium revenue, adjusted EPS of $0.89, a 92.9% consolidated MCR, a 6.3% adjusted G&A ratio, and a 0.6% adjusted pre-tax margin for the third quarter. Year-to-date adjusted pre-tax margin was 1.1%.

Negative Updates

Elevated Medical Cost Trend

Management increased its full-year 2026 medical cost trend outlook from 5%-5.5% to 5.5% because of elevated utilization in several medical cost categories and a slight acuity shift. LTSS and behavioral health trends remained elevated, while outpatient services and high-cost drugs were slightly higher.

Company Guidance

For 2026, Molina reaffirmed premium revenue guidance of approximately $42 billion and adjusted earnings guidance of at least $5.25 per share, with consolidated MCR at 92.6%, adjusted G&A ratio at approximately 6.4%, Medicaid MCR at 92.9%, Medicare MCR at 92.2%, and Marketplace MCR at 90%; guidance now includes rates at 4.5% and trend at 5.5%, with implied fourth quarter adjusted EPS of $0.50, Medicaid MCR of 93.6% (92.5% excluding Florida CMS), Medicare MCR of 94.7%, and Marketplace MCR of 96.1%. For 2027, premium revenue is expected to be at least $45 billion, preliminary EPS building blocks sum to more than $9.50 per share, known embedded earnings remain approximately $9 per share, and $4 per share of embedded earnings is expected to be harvested, while Medicaid rates may approximate 6%, medical cost trend is projected in a range of 5.5%-6% including 50 basis points of conservatism, membership attrition is expected to be 6%, Marketplace is expected to reach at least breakeven, and every 100 basis points of Medicaid MCR is worth approximately $5 per share.

Molina Healthcare Risk Analysis

Molina Healthcare disclosed 41 risk factors in its most recent earnings report. Molina Healthcare reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Molina Healthcare Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:MHG against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ELV	76Outperform	$92.79B	18.35	11.59%	1.60%	3.60%	-4.06%
CI	75Outperform	$79.43B	13.05	14.10%	2.09%	6.79%	-0.38%
CNC	66Neutral	$34.89B	23.75	6.78%	―	9.71%	―
UNH	62Neutral	$361.04B	23.14	16.35%	2.24%	3.33%	-8.75%
HUM	58Neutral	$53.60B	42.59	6.70%	0.80%	22.02%	-3.07%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:MHG and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:MHG	Molina Healthcare Inc	187.05	68.70	58.05%
CNC	Centene	70.27	33.89	93.16%
CI	Cigna	296.27	32.59	12.36%
HUM	Humana	443.68	209.62	89.55%
UNH	Unitedhealth Group Inc.	405.13	91.62	29.22%
ELV	Elevance Health, Inc.	429.90	110.42	34.56%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Molina Healthcare AI Stock Analysis